In this video, we're going to be talking about the top five penny stocks that will be spiking in August 2019. Now, the reason that I could say this conclusively is not because I have a magical ball, but rather because the companies on this list literally tell you the exact date at which price changing events will occur. They do this through, of course, telling us about their FDA approvals face trial data releases as well as dropping many hits and clues to lead us to the right conclusion. But I do want to take a moment to emphasize the fact that these aren't stocks to just buy and randomly hold? Most of the stocks on this list will bring a decent amount of hype around the time of the catalyst, but they almost always revert in the opposite direction after the hype.

This is because the stock market is irrational in the short term, but in the long run tends to converge to the true value. So if we're trading, the fluctuation and the price action, we're going to need to have a concrete entry point and a concrete exit point. And of course, you're also going to want to do your own research. But the research in this video should serve as a good foundation to get you started on your own research.

And once you've done your research, I still recommend waiting for a technical confirmation in the price action, making sure that the price action backs up your research before you actually act on it. But anyways, that's enough with the warnings. The only thing that I ask of you in return for this video is the cost of one ravishing mic button For just one ravishing like button. This whole video, everything in it will be worth it to me and of course also subscribing for more short sweet simplified videos on how to trade the stock market.

Ok so a quick plug if you would like to trade the stocks on this list commission-free Would like a free stock for doing so and would also like to support this channel. My recommendation is to check out Weeble. They are an excellent broker curtailed specifically for us as traders and really it's a pretty easy platform to use, but if you sign up with them below, you will get a free stock just for doing so, so might as well check it out. Okay, so EVOC has been a zip trader darling for quite a while.

It provides beautiful price action and then let you down like a winter gnome in the summertime, but it got beat down so badly that now we are at this insane discount with early warning signs of an uptrend with it building directional strength over our red directional SMA line. And this is quite exciting considering we have so little downward potential as compared to upward potential. but you add sugar to this fire. EVOC will have on July 26th with the FDA and this is Eve ox opportunity to use this as a way to pump up their desperate price action.

but it also allows investors a glimpse of light at the end of the tunnel. Any positive step in the FDA approval process can bring in massive price changes, and the fact that this has already been discounted so far puts it in favor of running on massively. If we do see some positive steps in this process, and while this play isn't technically in August, a lot of the price action will undoubtedly take place in August and my suggestion is to wait to get in at a good deal while also keeping an eye for a confirmation point. We want to play to the upside of this, but we also want to make sure that we aren't going to be buying into a straight-up downtrend and we do see some signs of consistent up trends now.

NBR V will have their FDA approval decision on August 19th for their drug for ammonia. So why do we care? Well PDUFA or final stage FDA Approvals tend to have around an 80% acceptance rate based on prior years. Doesn't mean it has to continue, but that's generally the rate and they tend to draw in massive amounts of investor interest. So with N Brv, we also have a prior history of providing news catalyst, price Action trade-off of.

So not only do we know that there's an 80 percent rate of approval, but N DRV also individually shows price action movement after news catalyst plays and FDA approvals are some of the biggest news Catalyst Plays For example, this spike in N. Brv happened after they announced that they were approved for EMA, which is essentially Europe's version of the Fda approval process. and that means that they're prepping for a new market. And this spike here happened after N.

Brv announced that they were seeking a meeting on contempo. So these run-ups happen in anticipation of new drugs entering new markets. and that means new revenue, new profitability, and more money for the company and more money for shareholders. And this latest FDA approval will be the latest chance N BRV has to bring in a new addition to the market.

and will it get approved? Well, there may be an 80% rate overall, but that doesn't mean if there is an 80% chance of it being approved, there's other factors at play. In fact, this overall failure of an upward reversal happened after NB RV's contempo. FDA approval got delayed so it may not get declined, but it doesn't have to get approved either. It could just be issued a C or L which is effectively a delay to fix issues.

So having this knowledge in mind, the best way to handle FD plays is to focus on price action and use the News Catalyst to put the price action on your radar. A lot of times people get confused when they see stocks going up 80 percent in one day, but if you keep track of these News Catalyst Plays, you're not going to be surprised when you see these. You're going to know ahead of time that certain stocks on these watch lists are going to breakout. Of course, you won't know which one's going to go up 80 percent, but if you have a list of 15 that are going up and you see one is really breaking out and you could focus on that, and that's going to give you a high probability of finding price action to trade off of.

And NBR V has some interesting price action. We have some periods of rapid over selling and over buying, followed by some fighting of price direction when we are below our red SMA line. That means we are in a downward direction, and when we are above, that means we are in an upward direction. So this acceptance of an uptrend keeps attempting reversals, but now is starting to show signs of a sustained upward direction.

It may not sustain, but what I'd recommend is placing this on your watchlist, waiting for a technical confirmation over both our directional SMA line as well as our price strength blue SMA line and making sure to take a position when you're near a good deal. It is important to ensure that you get in at at least below or near fair value. The goal with these plays is to maximize your upside while minimizing your downside, while also while also planning to take advantage of the catalysts. The whole goal with this is we use the catalyst and then we use the price action to create the catalyst, but going a little bit more into the fundamentals.

This particular analyst and I have enjoyed reading these articles, but this one analyst made a pretty good case for an abbreviated the passage of both Contempo and Lef a Mullen which the latter is the FDA approval that we started this conversation on. we're quite certain, but then surprise hit with Contempo being issued ACRL which is again a delay to fix issues. Now this allowed the price to be discounted, but it also allowed us to be at a point where we have two potential catalysts now not just one, but two. We have a specific date for the second one, which is what was it? August 19th.

Yeah, it was August 19th. So now we have two of the most powerful catalysts that a company can have in this sector to FDA approvals. So these two pending FDA approvals can be quite a beautiful thing. and the CRL for contempo was issued due to a resolvable manufac to an issue according to analysts and some of my own research.

and if this is how far it ran up in anticipation of contempo being approved, it's only fair to say that a pending approval of contempo combined with the FDA approval play on the 19th will cause some running up an anticipation. If approval hits, and if approval hits, we should see a massive spike upward. Okay, the third on our list is Cola. Now Cola will have their FDA approval decision on August 15th for their drug for dry eye disease.

But before you blink, one of the things that I've always hated about penny stocks is that most of them are consistently down trending. This is a huge deprecating factor because even if you do everything right, odds are strong that it ends up going down after any push backs. And that is a sad reality with penny stocks. They're not called penny stocks because they're lucrative flowers.

So with this in mind, my suggestion is to focus on finding catalysts and then waiting for directional strength. For example, we could gamble and buy in here in hopes that the FDA approval both works out and causes a positive run-up. but the price action does not warrant that we are in a downward direction, both under our red directional SMA line as well as a negative price strength territory under our blue SMA line. This is not acceptable and is not a point of confirmation.

I Understand that a lot of folks get upset because waiting for price strength means that you're going to be eating into some of your upside. And that's fine. We have upward potential from 566 to 925, which is three dollars and 59 sets of upward potential to a relative 86 cents of downside. So there is enough upside to eat into in order to get a more sure entry point.

There's just no reason to take risky positions at stocks that are going downhill, so be patient it. Wait until the price action tells you it makes sense. You are going to be better off in the long run waiting on high probability entry points. Okay, now V NDA will have their FDA approval decision on August 16th Now V NDA is not a penny stock by any means as the wonderful SEC defines a penny stock as anything under $5 So I didn't include it in the number account for the video because that would have been unfair.

But I am going to include it in this video because it has a major FDA approval and so it's pretty relevant to the topic at hand. And honestly, it's been getting railroaded like a lot of the other ones on this list. But because of this massive discount, an FDA approval could completely change the direction and V NDA is a pretty solid one of the only companies on this list that I would say is actually solid. The analysts have declared a upward sloping growth expectation and the company has absolutely no debt on its balance sheet.

For those of you who love buying undervalued companies, this could perhaps be a pretty good undervalued company contingent on a few factors though. But anyways, this beat down has given it plenty of room to grow with no debt weighing it down, and while we as traders couldn't care less about a company's long-term growth potential, we know that this is the sort of thing that brings investors in. and when investors all come in upon an FDA approval decision, this allows us to trade off of their inbound fluctuations. But moreover, this downward pattern has led to Shorts earning a decent profit.

but the level of Shorts has decreased from the prior settlement date has short biased investors are getting more squeamish before the FDA approval decision, but there is still enough short interest to create a helpful short squeeze if we do see some rapid appreciation. All right now, Mr. NS is attempting to solve the outbreak of new mothers being depressed after giving birth. This is known as postpartum depression aka when you bring a newborn baby home and you realize it is just a crying germ ball.

So in honor of all these new mothers, it's time to profit off the price action. We have an overall downward direction with recent attempts and rejections of upward reversals. What I'll be looking for is a holding off of upward direction and technical confirmation. Going into August and the third fiscal quarter, a slew of action can give birth to $6.63 of upward potential and a stock that has a previous pattern of running up massively in a few week time span.

Make sure to get in at a good deal and a price confirmation. I Say this all the time, but always wait for confirmation until the day I die I will remind you wait for confirmation folks. on my tombstone it will say Charlie waiting for confirmation We don't take positions because we feel like it's a right time, but rather when the price action confirms it all right now, Ntek and text price action is blatantly disgusting. Makes me want to gag.

but Ntek will have their phase 3 day to release late July or sometime in August most likely in August for their drug for advanced Parkinson's now every family has an Aunt Susan who has great intentions, but we still know inside that she's going down fast. This is a woman that's going off the cliff. so Ntek is sort of the Aunt Susan of Biopharma. But much like with Aunt Susan, we haven't given up hope and Tech just recently provided some beautiful price action back in late 2018 with over buying and over selling.

This phase data released could mark the start of a new trend. and this discount means that they have a lot of upside. But phase data releases aren't going to be events that recover all of this upside. they're just.

they're just not strong enough of catalysts, but they are going to be relevant in that they can serve as a starting point to a reversal. But that alone isn't enough for me to go gung-ho over this position. Rather, it's the institutional money throwing their hat into the ring. Since Q2 of 2017, we've seen institutional investors rise massively and where the smart money flows, the dumb money follows.

This is the sort of thing that I love to see in the Biotech world. Institutional investors tend to bring a lot of hype with them, and while hedge funds are having a hard time performance wise, they still carry with them a certain amount of prestige. It helps a lot of these small caps. then Bio Select Advisor has the largest stake and if you look at their filings you can see they hold a decent amount of exposure and many value plays and big names throughout the Biopharm world and many that we've covered in previous videos.

And if you look at their returns, they have some horrendous numbers. But that's fine because Bio funds like this one specialize in creating long-term profit from holding these place. And when they place a company like this in their portfolio that effectively endorses it for long term growth. Now, does this mean that it will continue to grow in the long run? Of course not.

but this is something that regular investors look for and it helps propagate the stock price if we do see a positive catalyst with phase data. Ok, so for those of you who are looking for a bigger challenge plate, if you felt that the other plays on this list aren't going to be challenging enough for you, IP CIF will have their FDA decision on August 28th for their drug for lower back pain. Now this is a low volume, low flow play with sporadic intraday movements. This is the only play on this list that is traded on the OTC markets and as you know, the OTC market is very similar to the Wild West.

Very unregulated, very dangerous, and a lot of bars. I Should also mention that since this is trade on the OTC, it won't be available on many of the platforms such as we Bowl or Robin Hood. but IP CIF has been showing price strength and I'd like to see it continue its uptrend in August before the FDA approval. At that point, we can use technical confirmation and a cost-benefit analysis to determine if it makes that to take a position based on the catalyst at hand.

When it comes to these sorts of lowbrow plays, these very poor quality plays I trend extremely lightly because of the simple fact that they could turn on the drop of a hat. My suggestion is to only take a position if the setup looks perfect. In terms of the fundamentals, IP CIF Did just announced a 10 million dollar equity financing deal and with the upcoming FDA approval decision, we could see a massive run-up. They have a history of running up massively in two week time periods and then getting beaten down afterwards, so this position will definitely be relevant going into August Anyways, I Do hope this video is helpful for you.

If you have any questions, you can feel free to reach out to us on the Zipp Creators Circle Facebook group or comment below. We also have a discord chat, a trading tutorials, playlist, and a bunch of other resources for you across the zip trader. Hemisphere If you are having a hard time keeping up with these plays, I Do post nightly watch lists on both the Discord Chat and my Facebook group which the links again are below and if you would like to find these Biotech plays yourself. I'll put the link below to the Bio Forum, a Catalyst website, but all you have to do is go on to their page, go to the FDA approval calendar, or the PDUFA list, and then scan for which stocks and Catalyst plays that you'd like, and then you can go on Google type in the different tickers and do your own due diligence to figure out which ones are the best opportunities for you.

But my suggestion is to make sure to always wait like you form your hypothesis using the research that you've done. but then you wait for the technical confirmation. Biotech research is great for putting stocks on your watchlist so that you can be aware when they start having movement, but after that you're going to want to wait for confirmation. Technical confirmation is very important Anyways, folks, good luck with all these plays.

Thanks for watching and I'll see you in the next video.